Conflu3nce Overview
Conflu3nce applies its patented methods to the early detection of cognitive health changes in people across the cognitive spectrum. The company is developing PICSSi, a minimally-disruptive, on-demand system that addresses cognitive-motor issues for people across a wide range of ages and conditions, including Alzheimers disease, traumatic brain injury, Parkinsons disease, stroke, and attention-deficit/hyperactivity disorder. The systems multi-modal, multi-domain-based personalized interactive units are designed to cooperatively engage global cognition and can be delivered as hands-on or virtual/view-only experiences. The company's PICSSi and Stitch and Peel (SnP) technology is based on processes and methods that use content-rich, dynamic, 3D-like figure-ground image sets with image properties that can be manipulated and predicted. For early detection, PICSSi can be personalized to capture an individuals cognitive expression pattern without bias toward disease/symptom trajectories or domain-specific deficits. User-specific baselines are used to detect changes in cognition over time. And for training/remediation, users are guided through increasingly challenging interactions to develop and retrain their skills, processes, and processing based on their dynamic progress.
Cumulative Funding Raised Over Time ($)
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $330K |
| Last funding | $30K |
| Stage | Pre-Seed |
| Rounds | 2 |
| Investors | 1 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | www.conflu3nce.com/ |
Locations
Emek Refa'im Street 30, P.O.Box 8514, Jerusalem 9108401, Israel
1181 South Parker Road, Suite 102, Denver, CO, USA
Photos & Videos
3 item(s)
Conflu3nce Business
Sector
Health Tech & Life SciencesDigital HealthcareDigital TherapeuticsTarget Customer
Healthcare & Life SciencesHealthcarePatientsCore Technology
Artificial IntelligenceComputer VisionPlatforms & InterfacesSoftwareSimulation & ImagingTags (26)
neurology3d-technologyneuro-stimulationalzheimers-diseaseinsurance-companiesnon-invasiveparkinsonmedical-devicesearly-detectioncomputer-visionartificial-intelligencehealthcare-providersmobile-applicationsseniorshospitalspharma-companiesdiagnosticstrainingdigital-healthcareadhddegenerative-diseasescognitive-trainingtreatmentsimage-processingdigital-therapeuticsrehabilitationGeographic Markets
GlobalConflu3nce Financials
Cumulative Funding Raised Over Time ($)
Private Equity Funding
Non-Equity Funding
Conflu3nce Lifecycle
Cumulative Funding Raised Over Time
All Events
Conflu3nce News
0 articlesNo news articles.
Conflu3nce Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 1 |
| Team members | 4 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 11 classification IDs that could be used for matching.
Conflu3nce Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 98/100 |
| Missing | news, markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 515436921 |
| Crunchbase | conflu3nce |
| Creator | Natalia Golczar |
| Creator email | ngolczar@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-03-20T00:00:00.000Z |
| Created | 2016-01-28T00:00:00.000Z |
| Claimed | Yes |